This profile describes access and programme structure. Inclusion is not an endorsement, regulatory finding, or clinical recommendation. Prescription decisions belong to a qualified prescriber.
At a glance
Pricing, medicine, location, care, fulfilment, funding, and policy claims are separated below.
An open check means the public sources were not specific enough—not that the service failed the check.
Resumen en español
Fella Health para usuarios hispanohablantes
Esta sección ofrece una orientación breve en español sobre el perfil estadounidense. La investigación completa de precios, acceso, farmacia y seguimiento permanece arriba mientras ampliamos la revisión editorial en español.
No encontramos una fuente primaria suficientemente específica para afirmar que una cita clínica esté disponible en español. Confirma el idioma y cualquier servicio de interpretación antes de pagar.
- si la cita concreta será en español;
- el coste mensual ordinario y qué incluye;
- la licencia estatal del profesional;
- el medicamento, la farmacia y el coste por separado.
Esta traducción editorial no demuestra que el proveedor ofrezca atención clínica en español y no sustituye una valoración médica.
Comparar proveedores para hispanohablantes en EE. UU. →How the program is structured
A men-focused, cash-pay program with clinician-selected compounded or LillyDirect Zepbound pathways, health coaching, free metabolic labs, home delivery, flat dose pricing, and a six-month guarantee governed by separate terms.
GLP.directory checked the cited public sources on Sep 13, 2026. We reviewed published access, cost, care, fulfilment, funding, cancellation, monitoring, and switching details; we have not audited individual clinical encounters, prescriptions, pharmacy operations, or outcomes.
Availability can change by state, clinician, medical history, product, pharmacy, inventory, and insurance plan. “Not publicly confirmed” means we did not find a sufficiently specific answer in the cited public material. Confirm the current patient-specific answer before paying or changing care.
Service configuration
These structured fields power the directory filters. They describe the reviewed public route and should be reconfirmed for the selected plan.
- Provider type
- Telehealth program
- Medicine context
- Tirzepatide (Zepbound; Mounjaro for type 2 diabetes)
- Formats reviewed
- Injection
- Funding routes
- Private pay
- Service features
- Coaching · Clinician support · Switching pathway · Home delivery
- Access check
- Confirm current state access
- Evidence status
- Primary sources reviewed
- Research depth
- 3 cited sources · 3 medicine rows · 4 open checks
Recurring cost breakdown
- Core program is advertised at less than $10/day.
- Medication cost, health assessment, medical support, health coaching, free labs, and home delivery are presented as included.
- Pricing is advertised as flat across prescribed doses.
- Exact plan duration, upfront charge, and renewal must be confirmed in checkout.
- Medicine + dose
- Membership or consultation
- Delivery + supplies
- Labs + follow-up
- Renewal after offers
Medication and formulation matrix
| Medication | Form | Regulatory / program path | Published price view |
|---|---|---|---|
| Personalized compounded GLP-1 plan | Weekly injection as prescribed | Not FDA-approved | Included in selected program; flat dose price |
| Zepbound via LillyDirect | Weekly injection | FDA-approved brand | Commercial plan; verify checkout total |
| Microdose compounded plan | Weekly low-dose injection | Not FDA-approved; not positioned for weight loss | Eligibility/checkout price |
Important: “Compounded” means the product is not FDA approved. A brand approved for one condition is not automatically approved for another. The treating clinician determines whether any prescription is appropriate.
State-by-state availability
- Fella publishes state-specific informational pages and serves the US through licensed clinicians.
- Exact compounded and commercial availability varies by state; confirm the patient’s location in intake.
Clinician access and follow-up cadence
- A clinician reviews the medical form and metabolic assessment.
- Health coaching and email check-ins support nutrition, exercise, sleep, and mental fitness.
- The microdose page describes follow-ups approximately every two to four weeks; other plan cadence should be confirmed.
Pharmacy and fulfillment
- Medication is delivered to the home.
- Compounded medication is prepared by licensed pharmacies; the specific partner is not named on the reviewed treatment page.
- Commercial Zepbound can use LillyDirect.
Insurance and prior authorization
- No insurance requirement is advertised for the core program.
- A patient-specific insurance pathway is not needed for the included cash program, though clinical choice can depend on coverage.
Cancellation, refund, and commitment
- Membership terms govern commitment and renewal.
- The six-month money-back guarantee has separate adherence and eligibility rules; it is not an unconditional cancellation refund.
Labs, monitoring, and dose management
- Free lab work is advertised locally or through an at-home kit.
- Existing labs from the prior 24 months may be accepted.
- The metabolic assessment informs treatment; ask what repeat testing is required.
Maintenance and switching
- Ongoing coaching is designed for sustainable habits.
- A transfer requires new clinician review; use recent labs and prescription history to reduce delay.
Program snapshot
Plan-based cash program
Profiled support: Ongoing clinician access, Coaching or behavior support.
Cash pay
The reviewed flow is direct cash pay.
Verify before purchase
The homepage names semaglutide and tirzepatide but does not clearly label the source as brand-name or compounded. Confirm the exact product and pharmacy.
What the advertised program may include
- Clinical assessment
- Medication access when prescribed
- Coaching/accountability
- Delivery on eligible plans
Useful comparison signals
Based on the provider’s published program structure, this profile is tagged for the following searches. These are filters, not endorsements or clinical recommendations.
- Starting care and comparing first-provider requirements
- Switching providers or continuing an established treatment
- Ongoing clinician access
- Coaching or behavior support
Open evidence gaps
These are material details we could not confirm precisely enough from the cited public pages. They are the highest-priority questions to resolve directly.
- Public exact core-plan total and term before quiz
- Named compounding pharmacy
- Universal follow-up cadence
- State-by-product matrix
Questions to ask before paying
- What is the ordinary recurring total after any introductory period?
- Does that total include clinician care, medication, supplies, labs, and shipping?
- Which clinician group and dispensing pharmacy will be responsible for my care?
- What happens to billing if I am not prescribed the advertised treatment?
- What records and timing do you require if I am switching from another provider?
Source ledger
Every entry below is a provider-controlled or official public source. A source link documents what was published; it does not independently validate performance, regulatory compliance, safety, or outcomes.
Treatment types, free labs, care, flat dose price and fulfillment
Billing, renewal and cancellation framework
Six-month guarantee eligibility and limitations